Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Receivables (2016 - 2025)

InspireMD filings provide 16 years of Receivables readings, the most recent being $2.6 million for Q4 2025.

  • On a quarterly basis, Receivables rose 13.93% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 13.93% increase, with the full-year FY2025 number at $2.6 million, up 13.93% from a year prior.
  • Receivables hit $2.6 million in Q4 2025 for InspireMD, up from $2.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.6 million in Q4 2025 to a low of $825000.0 in Q1 2021.
  • Median Receivables over the past 5 years was $1.7 million (2023), compared with a mean of $1.7 million.
  • The widest YoY moves for Receivables: up 123.31% in 2021, down 19.9% in 2021.
  • InspireMD's Receivables stood at $1.4 million in 2021, then dropped by 10.22% to $1.2 million in 2022, then surged by 96.63% to $2.5 million in 2023, then decreased by 8.08% to $2.3 million in 2024, then grew by 13.93% to $2.6 million in 2025.
  • The last three reported values for Receivables were $2.6 million (Q4 2025), $2.4 million (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.